What is PURR's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 3.09B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for PURR?

P/E (TTM) is n/a and 52-week range is $3.01 to $14.76 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s PURR figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Where is Hyperliquid Strategies Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in New York City, New York, US, 134.6M shares outstanding, ISIN US44916Y1064 when available from company profile and filing metadata.

Hyperliquid Strategies Inc

$PURR

Health Care · Biotechnology

Run Scenarios

$11.11

-1.68%

Hyperliquid Strategies Inc

$PURR

Health Care · Biotechnology

Run Scenarios

$11.11

-1.68%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

IPO

2025-12-03

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US44916Y1064

Headquarters

New York City, New York, US

Shares outstanding

134.6M

NAICS sector

Information

Institutional ownership

60.99%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

IPO

2025-12-03

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)